Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
56,362,930
-
Share change
-
-4,562,638
-
Total reported value
-
$323,576,998
-
Put/Call ratio
-
224%
-
Price per share
-
$5.74
-
Number of holders
-
140
-
Value change
-
-$33,068,798
-
Number of buys
-
78
-
Number of sells
-
51
Institutional Holders of CYMABAY THERAPEUTICS INC - COM (CBAY) as of Q4 2020
As of 31 Dec 2020,
CYMABAY THERAPEUTICS INC - COM (CBAY) was held by
140 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,362,930 shares.
The largest 10 holders included
Avoro Capital Advisors LLC, BlackRock Inc., BOXER CAPITAL, LLC, VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, CITADEL ADVISORS LLC, STATE STREET CORP, Foresite Capital Management IV, LLC, Foresite Capital Management III, LLC, and COMMODORE CAPITAL LP.
This page lists
140
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.